Sascha A Tuchman (Sascha Tuchman)

Publication Activity (10 Years)

Years Active: 2014-2022
Publications (10 Years): 12

Top Topics

Clostridium Difficile

Acute Lymphoblastic Leukemia

Monoclonal Antibody

Top Venues

Blood cancer journal

JCO oncology practice

Hematological oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Ghulam Rehman Mohyuddin, Rajshekhar Chakraborty, Gregory Sampang Calip, Mustafa S Ascha, Xiaoliang Wang, Samuel M Rubinstein, Sascha A Tuchman, Luciano José Megale Costa, Benjamin Haaland, Smith Giri, Hira S Mian, Rafael Fonseca, Douglas W Sborov
Prognostic value of translocation 11;14 in patients with relapsed/refractory myeloma receiving anti-CD38 therapy. Blood cancer journal 12 (12) (2022)
Shakira J Grant, Matthew Jansen, Tzy-Mey Kuo, Samuel M Rubinstein, Tanya M Wildes, Sascha A Tuchman, Hyman B Muss, Eben I Lichtman, Marjory Charlot
Cross-Sectional Analysis of Clinical Trial Availability and North Carolina Neighborhood Social Vulnerability. JCO oncology practice (2022)
Ghulam Rehman Mohyuddin, Rajshekhar Chakraborty, Gregory Sampang Calip, Mustafa S Ascha, Xiaoliang Wang, Samuel M Rubinstein, Sascha A Tuchman, Luciano José Megale Costa, Benjamin Haaland, Smith Giri, Hira S Mian, Rafael Fonseca, Douglas W Sborov
Prognostic value of translocation 11;14 in patients with relapsed/refractory myeloma receiving anti-CD38 therapy. Blood cancer journal 12 (12) (2022)
Ghulam Rehman Mohyuddin, Rajshekhar Chakraborty, Gregory Sampang Calip, Mustafa S Ascha, Xiaoliang Wang, Samuel M Rubinstein, Sascha A Tuchman, Luciano José Megale Costa, Benjamin Haaland, Smith Giri, Hira S Mian, Rafael Fonseca, Douglas W Sborov
Prognostic value of translocation 11;14 in patients with relapsed/refractory myeloma receiving anti-CD38 therapy. Blood cancer journal 12 (12) (2022)
Ghulam Rehman Mohyuddin, Rajshekhar Chakraborty, Gregory Sampang Calip, Mustafa S Ascha, Xiaoliang Wang, Samuel M Rubinstein, Sascha A Tuchman, Luciano José Megale Costa, Benjamin Haaland, Smith Giri, Hira S Mian, Rafael Fonseca, Douglas W Sborov
Prognostic value of translocation 11;14 in patients with relapsed/refractory myeloma receiving anti-CD38 therapy. Blood cancer journal 12 (12) (2022)
Ghulam Rehman Mohyuddin, Rajshekhar Chakraborty, Gregory Sampang Calip, Mustafa S Ascha, Xiaoliang Wang, Samuel M Rubinstein, Sascha A Tuchman, Luciano José Megale Costa, Benjamin Haaland, Smith Giri, Hira S Mian, Rafael Fonseca, Douglas W Sborov
Prognostic value of translocation 11;14 in patients with relapsed/refractory myeloma receiving anti-CD38 therapy. Blood cancer journal 12 (12) (2022)
Ghulam Rehman Mohyuddin, Rajshekhar Chakraborty, Gregory Sampang Calip, Mustafa S Ascha, Xiaoliang Wang, Samuel M Rubinstein, Sascha A Tuchman, Luciano José Megale Costa, Benjamin Haaland, Smith Giri, Hira S Mian, Rafael Fonseca, Douglas W Sborov
Prognostic value of translocation 11;14 in patients with relapsed/refractory myeloma receiving anti-CD38 therapy. Blood cancer journal 12 (12) (2022)
Karthik Ramasamy, Ajay K Nooka, Hang Quach, Myo Htut, Rakesh Popat, Michaela Liedtke, Sascha A Tuchman, Jacob P Laubach, Cristina Gasparetto, Asher Chanan-Khan, Mark Hertzberg, Mark deMario, Eveline Nueesch, Evelyne Chesne, Izolda Franjkovic, Katharina Lechner, Martin Kornacker, Hearn Jay Cho
A phase 1b dose-escalation/expansion study of BET inhibitor RO6870810 in patients with advanced multiple myeloma. Blood cancer journal 11 (9) (2021)
Carlos Fernández de Larrea, Robert Kyle, Laura Rosinol, Juan José Lahuerta, Monika Engelhardt, Saad Z Usmani, Jo Caers, Wilson Gonsalves, Schjesvold Fredrik, Giampaolo Merlini, Suzanne Lentzch, Enrique Ocio, Laurent Garderet, Philippe Moreau, Pieter Sonneveld, Ashraf Badros, Gösta Gahrton, Hartmut Goldschmidt, Sascha A Tuchman, Hermann Einsele, Brian Durie, Baldeep Wirk, Pellegrino Musto, Patrick Hayden, Martin F Kaiser, Jesús San F Miguel, Joan Bladé, Sundararajan Vincent Rajkumar, Maria-Victoria Mateos-Manteca
Primary plasma cell leukemia: consensus definition by the International Myeloma Working Group according to peripheral blood plasma cell percentage. Blood cancer journal 11 (12) (2021)
Saad Z Usmani, Chatchada Karanes, William I Bensinger, Anita D Souza, Noopur Raje, Sascha A Tuchman, Douglas Sborov, Jacob P Laubach, Giada Bianchi, Dheepak Kanagavel, Rao Saleem, Franck Dubin, Frank Campana, Paul Gerard Richardson
Final results of a phase 1b study of isatuximab short-duration fixed-volume infusion combination therapy for relapsed/refractory multiple myeloma. Leukemia 35 (12) (2021)
Jacob P Laubach, Sascha A Tuchman, Jacalyn M Rosenblatt, Constantine S Mitsiades, Kathleen Colson, Kelly Masone, Diane Warren, Robert A Redd, Dena Grayson, Paul Gerard Richardson
Phase 1 open-label study of panobinostat, lenalidomide, bortezomib + dexamethasone in relapsed and relapsed/refractory multiple myeloma. Blood cancer journal 11 (2) (2021)
Li-Wen Huang, Wendi Bacon, Constance Cirrincione, Bercedis Peterson, Gwynn Long, David Rizzieri, Keith M Sullivan, Kelly Corbet, Mitchell Horwitz, Nelson Chao, Cristina Gasparetto, Sascha A Tuchman
Efficacy and safety of high-dose chemotherapy with autologous stem cell transplantation in senior versus younger adults with newly diagnosed multiple myeloma. Hematological oncology 35 (4) (2017)
Sascha A Tuchman, Wendi A Bacon, Li-Wen Huang, Gwynn Long, David Rizzieri, Mitchell Horwitz, John P Chute, Keith Sullivan, Ashley Morris Engemann, Amanda Yopp, Zhiguo Li, Kelly Corbet, Nelson Chao, Cristina Gasparetto
Cyclophosphamide-based hematopoietic stem cell mobilization before autologous stem cell transplantation in newly diagnosed multiple myeloma. Journal of clinical apheresis 30 (3) (2014)